For a meaningful share of colicky infants, the driver isn't gas in the moment, it's an underlying imbalance in the gut microbiome that produces excess fermentation, inflammation, and heightened pain perception on an ongoing basis. That's a different problem than "gas after a feed," and it responds to a different kind of intervention.

What gut microbiome disruption actually looks like

Fermentation and inflammation, not just gasExcess fermentation plus a more reactive gut lining is why the same amount of gas can produce very different crying responses.

In the first weeks of life, an infant's gut microbiome is still establishing itself, and in some babies that process runs into imbalance, specifically a shortage of certain protective bacterial strains relative to gas-producing ones. The result is excess fermentation of feed contents, which produces gas, and a gut lining more reactive to normal digestive activity than it would be otherwise, which raises how much pain a given amount of gas or distension actually produces. This is why two babies can have what looks like a similar amount of gas and have very different crying responses to it. The gas isn't the whole story. The gut's reactivity to it is doing real work too.

The evidence base, in full

The foundational trial here is Savino et al. (Pediatrics, 2010), a randomized controlled trial that found a specific probiotic strain produced a significant reduction in daily crying time over three weeks. It's worth being precise about this trial's population: it was conducted exclusively in breastfed infants, and that caveat matters, not as a footnote, but as a real boundary on what the trial actually demonstrated. The full mechanism and result set are covered in more depth in our dedicated breakdown of that trial.

What's less commonly cited, and worth naming directly, is the broader evidence behind it. A network meta-analysis (Gutiérrez-Castrellón et al., 2017, published in Medicine, Baltimore) pooled 32 trials and 2,242 patients across colic interventions and ranked this specific probiotic strain first among them. That's a considerably larger evidence base than a single trial, and it's the citation that should be behind the "network meta-analysis" claim whenever it gets referenced, rather than a vague, unattributed mention of it. Systematic reviews since then, Ellwood, Draper-Rodi and Carnes (BMJ Open, 2020) and Hjern, Lindblom, Reuter and Silfverdal (Acta Paediatrica, 2020), have reinforced the same direction of evidence.

Why "any probiotic" doesn't work the same way

One studied strain, not a categoryL. reuteri DSM 17938, sold as BioGaia Protectis. A different strain hasn't inherited this evidence.

This is the detail that gets lost the most in casual coverage of this research. The evidence base isn't for "probiotics" as a category. It's specific to one strain: Lactobacillus reuteri DSM 17938, the strain studied in the trials above and sold commercially as BioGaia Protectis. A different Lactobacillus strain, or a generic multi-strain probiotic blend, has not been tested in this population and doesn't inherit the evidence from a strain it isn't. Strain specificity is not a minor technicality here, it's the difference between an evidence-based intervention and a product riding on the general credibility of the word "probiotic."

The breastfed vs formula-fed difference, stated plainly

Because the foundational RCT enrolled exclusively breastfed infants, the evidence for this specific strain in a formula-fed population is genuinely thinner, not equivalent with a different citation swapped in. If your baby is formula-fed or mixed-fed, this is worth knowing before assuming the same intervention applies the same way. The formula-feeding colic guide covers what's actually different for that population and what the honest evidence gap means in practice.

Not sure if a gut imbalance is even your baby's primary driver?

Take the free assessment →

What the dose actually is, and why the number is worth knowing

The trials above used a dose of roughly 10⁸ CFU daily, delivered as five drops. Naming that number is deliberate. Precise numbers are checkable, and a buyer who verifies things deserves an exact figure to verify rather than a vague gesture at "the right amount." What the number alone doesn't tell you is how to calibrate timing and delivery for your baby's specific feeding method, or how to sequence gut correction alongside a nervous-system or feeding-mechanics issue if more than one system is involved, which is where the calibration detail inside the Blueprint does the remaining work.

Get the full dosing calibration and diagnostic sequence

The Calm Baby Blueprint includes feeding-method-specific timing, the multi-system decision tree, and the tracker to see what's actually working.

Get the Blueprint, $47 →